Dr. Meiyu Fang 方美玉
Chief Physician
Department of Medical Oncology for Head and Neck and Rare Tumors, Zhejiang Cancer Hospital, Hangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Medical treatment of malignant melanoma, bone and soft tissue sarcomas, and rare tumors of the head, neck, and urogenital systems. Expertise includes chemotherapy, targeted therapy, hyperthermia, immunotherapy, and pain management for these conditions and elderly patients with cancer.
Dr. Fang has worked in medical oncology since 1996 and holds a doctorate in oncology. Dr. Fang was a visiting scholar at Charité – Universitätsmedizin Berlin (Humboldt University). Current clinical focus includes thyroid carcinoma, head and neck squamous cell carcinoma, salivary gland cancer, melanoma, sarcoma, and cancers of unknown primary origin.
Professional roles
- Chief, Department of Head and Neck and Rare Tumors
Name order: in Chinese the family name comes first (Fang Meiyu). Papers usually list the name as Meiyu Fang or Fang M.
Selected publications
85 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- Mol Genet Genomic Med, 2026 (senior author): Clinical Features and Treatment Strategies of Li-Fraumeni Syndrome Patients With Inherited TP53 Mutations. PubMed 41498535
- Cancer Med, 2023 (senior author): Clinical outcomes and biomarkers of phyllodes tumors of the breast: A single-center retrospective study. PubMed 37081723
- Front Oncol, 2021 (senior author): Corrigendum: Chemoresistance and Metastasis in Breast Cancer Molecular Mechanisms and Novel Clinical Strategies. PubMed 34485165
- J Multidiscip Healthc, 2021 (senior author): Remarkable Response of Toripalimab Combined with Chemotherapy in Sarcomatoid Carcinoma of Palatine Tonsil: A Case Report. PubMed 33727822
- Cancer Lett, 2021 (senior author): Non-coding RNA in thyroid cancer - Functions and mechanisms. PubMed 32949678
- Front Oncol, 2020 (senior author): Efficacy of Pyrotinib in HER2-Overexpressing Salivary Duct Carcinoma With Lung Metastasis: A Case Report. PubMed 33123470
- Transl Cancer Res, 2020 (senior author): Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective study. PubMed 35117215
- Transl Cancer Res, 2020 (senior author): Treatment and prognosis of primary malignant melanoma of the esophagus. PubMed 35117783
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion